Breast Cancer
Conference Coverage
Dr. Ingrid A. Mayer on neoadjuvant endocrine therapy: The times are changing
SAN ANTONIO – More phase 2 neoadjuvant endocrine therapy breast cancer trials are needed to inform design of phase 3...
Conference Coverage
DTCs in marrow herald worse outcomes for early breast cancer
SAN ANTONIO – Disseminated tumor cells detected in marrow at diagnosis or primary surgery for early breast cancer are associated with worse...
Conference Coverage
Exercise during adjuvant breast cancer therapy improves CV outcomes
SAN ANTONIO – A tailored 12-month exercise program during adjuvant breast cancer treatment appears to protect...
Conference Coverage
Oxybutynin nets dramatic reduction in hot flashes
SAN ANTONIO – The 6-week reduction in a hot flash score capturing both frequency and severity was about 30% with placebo, 65% with oxybutynin 2.5...
Conference Coverage
Extent of breast surgery is tied to quality of life among young breast cancer survivors
SAN ANTONIO – Younger breast cancer patients who undergo unilateral or bilateral mastectomy report lower breast satisfaction and poorer...
Conference Coverage
pCR may obviate need for adjuvant chemotherapy
SAN ANTONIO – A meta-analysis finds no added event-free survival benefit from adjuvant chemotherapy among the 21.1% of patients who achieved a pCR...
Conference Coverage
Extended anastrozole improves DFS, distant DFS
SAN ANTONIO – Extending treatment to 10 years significantly improved DFS and distant DFS in postmenopausal women...
Conference Coverage
Tamoxifen at 5 mg halves recurrence of breast intraepithelial neoplasia
SAN ANTONIO – For patients with ADH, DCIS, or LCIS, one-fourth of the standard dose reduced risk for both invasive disease/DCIS and contralateral...
Conference Coverage
TNBC survival appears better when adjuvant chemotherapy is delivered within 30 days
SAN ANTONIO – The longer the delay in initiating adjuvant chemotherapy, the worse the survival in patients with...
Conference Coverage
CTC matches MD judgment for mBC therapeutic choice
SAN ANTONIO – For patients with ER-positive, HER2-negative metastatic breast cancer, the use of CTC counts can help clinicians decide between...
Conference Coverage
RT of lymph nodes as good as dissection for the long-term
SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage...